Kristen Barton

Kristen Barton is a managing director and co-director of investment research. Kristen is also a senior research analyst focusing on agriculture & biotech companies. Prior to joining Tech Insider in 2010, Barton worked in equity research at RBC Capital Markets in Minneapolis, MN and Edward Jones in St. Louis, Mo. She was recognized for her stock picking in the 2012 Wall Street Journal "Best on the Street" publication.

NASDAQ Losers: Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Himax Technologies, Inc. (NASDAQ:HIMX), Blue Earth Inc. (NASDAQ:BBLU), Omeros Corporation (NASDAQ:OMER), Net Element International Inc (NASDAQ:NETE)

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases, announced the Defense Advanced Research Projects Agency (DARPA) has awarded $12.2 million for a collaborative study that will be conducted by scientists from the Perelman School of Medicine at the University…

Read More

Spark Infrastructure Reports Impressive First Half Results

Spark Infrastructure reported a solid first-half 2013, with earnings before interest, tax, depreciation and amortisation, or EBITDA, increasing 11% to AUD 340 million on a proportional basis. Growth was driven by substantial tariff increases to recover increased investment, partly offset by lower volumes. Regulated asset base (RAB) grew 9% in the past year and will…

Read More

Trending Tickers : Tekmira Pharmaceuticals Corp. (NASDAQ:TKMR), Monolithic Power Systems Inc. (NASDAQ:MPWR), Fleetmatics Group PLC (NYSE:FLTX), General Motors Company (NYSE:GM), Kindred Healthcare Inc. (NYSE:KND)

Tekmira Pharmaceuticals Corp. (NASDAQ:TKMR) announced the presentation of preclinical results characterizing TKM-HBV, a therapeutic agent targeting human hepatitis B virus (HBV), at the 10th Annual Meeting of the Oligonucleotide Therapeutics Society. Tekmira’s Chief Technical Officer, Dr. Ian MacLachlan delivered a podium presentation titled, “Update on the Preclinical Development of an LNP-Based HBV Therapeutic.” The conference…

Read More

Estee Sees Sales Increase 7% in Quarter

Estee Lauder has not been swayed by slowing global economic growth or competitive pressures, as evidenced by its continued top-line growth and margin expansion. Fourth quarter sales popped 7% (excluding foreign currency movements)–even more impressive as it came on top of 12% growth in the year-ago period. Investors were encouraged the firm is decentralizing innovation…

Read More

Trader’s Watch List : Oracle Corporation (NYSE:ORCL), Xerox Corporation (NYSE:XRX), Murphy Oil Corporation (NYSE:MUR), Delta Air Lines, Inc. (NYSE:DAL), CR Bard (NYSE:BCR)

director of the company’s Indian subsidiary, Oracle India Pvt. Ltd., has quit, but denied a report that his exit was linked to allegations of bribery. Oracle Corporation (NYSE:ORCL) belongs to Technology sector. Its net profit margin is 28.40% and weekly performance is -3.05%. On last trading day company shares ended up $37.56. Oracle Corporation (NYSE:ORCL)…

Read More

Investors Are Watching : LyondellBasell Industries N.V. (NYSE:LYB), Applied Materials, Inc. (NASDAQ:AMAT), Heritage Insurance Holdings, Inc. (NYSE:HRTG), Linn Energy (NASDAQ:LINE), American Express (NYSE:AXP)

LyondellBasell Industries NV (NYSE:LYB) EVP Craig B. Glidden sold 13,003 shares of LyondellBasell Industries NV stock in a transaction dated Wednesday, October 1st. The shares were sold at an average price of $105.47, for a total transaction of $1,371,426.41. Following the completion of the transaction, the executive vice president now directly owns 209,118 shares in…

Read More